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Abstract
Objective
Stress induced hyperglycemia occurs in critically ill patients who have normal glucose toler-
ance following resolution of their acute illness. The objective was to evaluate the associa-
tion between stress induced hyperglycemia and incident diabetes in survivors of critical
illness.
Design
Retrospective cohort study.
Setting
All adult patients surviving admission to a public hospital intensive care unit (ICU) in South
Australia between 2004 and 2011.
Patients
Stress induced hyperglycemia was defined as a blood glucose 11.1 mmol/L (200 mg/dL)
within 24 hours of ICU admission. Prevalent diabetes was identified through ICD-10 coding
or prior registration with the Australian National Diabetes Service Scheme (NDSS). Incident
diabetes was identified as NDSS registration beyond 30 days after hospital discharge until
July 2015. The predicted risk of developing diabetes was described as sub-hazard ratios
using competing risk regression. Survival was assessed using Cox proportional hazards
regression.
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Main Results
Stress induced hyperglycemia was identified in 2,883 (17%) of 17,074 patients without dia-
betes. The incidence of type 2 diabetes following critical illness was 4.8% (821 of 17,074).
The risk of diabetes in patients with stress induced hyperglycemia was approximately dou-
ble that of those without (HR 1.91 (95% CI 1.62, 2.26), p<0.001) and was sustained regard-
less of age or severity of illness.
Conclusions
Stress induced hyperglycemia identifies patients at subsequent risk of incident diabetes.
Introduction
Stress induced hyperglycemia occurs in critically ill patients in whom glucose tolerance was
previously normal, with hyperglycemia resolving following recovery [1]. This acute derange-
ment is observed frequently; within 48 hours of intensive care unit (ICU) admission up to 50%
of critically ill patients are hyperglycemic [2]. Stress induced hyperglycemia is known to be a
marker of illness severity, with the magnitude of hyperglycemia strongly associated with short-
termmortality, particularly in patients without a history of diabetes [2, 3].
The pathophysiology of stress induced hyperglycemia is thought to reflect temporary insu-
lin resistance coupled with relative insulin deficiency, in that plasma insulin concentrations are
inadequate to compensate for hyperglycemia [1]. Insulin resistance is driven by the stress
response to critical illness initiating an overwhelming activation of pro-inflammatorymedia-
tors (tumour necrosis factor-α, interleukin-6) and counter-regulatory hormone excess (gluca-
gon, cortisol, catecholamines) which lead to excessive hepatic gluconeogenesis and down-
regulation of insulin-mediatedGLUT-4 glucose transporters [4]. Whether critical illness
unmasks latent insulin resistance and/or impaired β-cell function has not been adequately
explored. The identification of long-termmetabolic derangements that are amenable to inter-
vention is important, particularly because outcomes for survivors of critical illness remain
poor, with up to 40% of patients dying within five years of hospital discharge [5].
The concept that transient hyperglycemia during critical illness identifies patients at
increased risk for developing type 2 diabetes is intuitively plausible. For example, there are sim-
ilarities between critical illness and gestational diabetes where an acute period of glucose intol-
erance initially normalises following resolution of the physiological challenge [6, 7]. While
gestational diabetes was once considered a temporary disorder of pregnancy, it is now recog-
nised that affected women are at high risk of developing type 2 diabetes [8, 9]. Moreover,
screening programs are advocated to detect early impairment in glucose tolerance because
intervention strategies in at-risk populations have been shown to reduce the progression to
type 2 diabetes [9, 10].
The primary aim was to evaluate the association between peak blood glucose in the first 24
hours of ICU admission and the subsequent risk of incident diabetes in survivors of critical
illness.
Research Design and Methods
The protocol was approved by the Research Ethics Committee of the Royal Adelaide Hospital,
the South Australian Department of Health and the Australian Institute of Health andWelfare,
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Patients
This was a retrospective,multi-centre observational study across all public hospital ICUs in
South Australia. Public intensive care services in South Australia (population 1.7 million) are
exclusively provided by four tertiary hospitals (FlindersMedical Centre, Lyell McEwin Hospi-
tal, Queen ElizabethHospital and Royal Adelaide Hospital). Patient demographic, hospital epi-
sode and intensive care admission data were extracted from each contributing ICU from
January 1 2004 to December 31 2011 inclusive. At each unit these data were collected prospec-
tively prior to submission to the Australia and New Zealand Intensive Care SocietyAdult
Patient Database (ANZICS-APD) [11]. The ANZICS-APD captures clinical, physiological, and
laboratory data for the initial 24 hours of ICU admission, along with outcome data, for all
patients admitted to ICUs across Australia and New Zealand [12]. These data were then linked
to population based datasets to match (i) International Classification of Diseases (ICD-10) cod-
ing of diabetes through the Department of Health Integrated South Australian Activity Collec-
tion dataset, generating a “known diabetes” flag for each hospital separation [13], (ii) socio-
economic status, estimated from the separation postcode using the Australian Bureau of Statis-
tics Index of Relative Socio-EconomicAdvantage and Disadvantage [14], (iii) mortality,
through the Australian National Death Index and (iv) incident diabetes, through registration
with the Australian National Diabetes Service Scheme (NDSS). The Australian Institute of
Health andWelfare performed data linkage between the composite ICU dataset and the NDSS
dataset and National Death Index. The NDSS dataset has more than one million Australians
registered as having type 2 diabetes [15].
Patients over the age of 18 years who survived ICU and were discharged from hospital alive
were assigned to one of three groups; (i) prevalent or ‘known’ diabetes, where either (a) ICD-
10 codes from the diabetes chapter (E10-E14) were present in the current or any prior hospital
separation, either as a principal diagnosis or a complication, (b) the patient was registered with
the NDSS as having diabetes prior to, or within 30 days of hospital separation, or (c) the peak
blood glucose was> 20 mmol/L (360 mg/dL) [16], (ii) stress induced hyperglycemia (SIH),
where diabetes was not prevalent (defined as above) and a recorded blood glucose 11.1
mmol/L (200 mg/dL) [2], and (iii) the control group, where diabetes was not prevalent and all
blood glucose levels were< 11.1 mmol/L (200 mg/dL). For patients with multiple ICU and/or
hospital episodes during the study period only the index admission was used such that each
patient was only included once in the final analysis.
New registration with the NDSS was used as a surrogate measure for incident diabetes, with
time to registration from 30 days post hospital discharge forming the primary study outcome,
as per McAllister and colleagues [16]. Secondaryoutcomes included the assessment of covari-
ates potentially influencing the time to NDSS registration and description of the survival pat-
terns between those with and without stress induced hyperglycemia.
Statistical analysis
Data are presented as frequencies and proportions for categorical variables and mean (standard
deviation) or median [interquartile range] for continuous variables. For NDSS registration,
time to event analysis was described as sub-hazard ratios using competing risk regression,
based upon the approach of Fine and Gray [17]. This was planned a priori, as death could not
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be considered a ‘non-informative’ censoring event. A sensitivity analysis was performed using
Cox proportional hazards regression, treating death as a censoring event. Patient survival was
assessed using Cox proportional hazards regression. For competing risks and Cox proportional
hazards models, between group effects are presented as sub-hazard ratio, SHR (95% CI) and
hazard ratio, HR (95% CI) respectively. Peak blood glucose levels between participating units
were compared using linear regression with ‘hospital’ as an indicator variable. Between group
comparisons were considered statistically significant at p< 0.05. Inclusion of covariates in
multivariate models was set at p< 0.1. All analyses were performed using Stata/MP 14.1
software.
Results
Baseline characteristics
A total of 31,007 patient separations were recorded during the capture period; 3,091 of these
had missing data, 1,292 with no matching SA Health record and 1,799 no available blood glu-
cose result. A further 5,443 were excluded due to either non-index ICU or hospital admission
status (5,078) or age less than 18 years (365), leaving 22,473 index separations. There were
5,399 (24%) patients with prevalent diabetes, leaving 17,074 patients for analysis; of these,
2,883 (17%) fulfilled the criteria for stress induced hyperglycemia and 14,191 (83%) formed the
control group (Fig 1). Demographic data are presented in Table 1. Patients were followed-up
for a maximum of 8 years post-discharge, with a median follow-up of 5.3 [3.6, 7.5] years.
Peak blood glucose differences between participating units
Despite minor heterogeneity in the glucose threshold at which intravenous insulin was com-
menced at each site (S1 Table), the mean peak glucose concentrations differed by 0.6 mmol/l
(10.8 mg/dL) between participating units (range 8.5–9.1 mmol/l (153–164 mg/dL), P< 0.0001,
S1 Fig).
NDSS capture rate of patients with prevalent diabetes
Of the 5,399 patients with prevalent diabetes, 4,176 were diagnosed based on ICD-10 coding
within the SA Health dataset. Following matching with the NDSS, 3,363 of these patients were
registered with the National Diabetes ServiceScheme, reflecting a capture rate of 80.5%.
Risk of incident diabetes post ICU discharge
Within the follow-up period, 4.8% (821 of 17,074) of patients newly registered with the NDSS
as having diabetes. Stress induced hyperglycemia increased the risk of incident diabetes with a
relative sub-hazard ratio 1.88 (1.61, 2.20), P< 0.001 (Fig 2). Demographic covariates (Table 1)
were entered into a multivariate model, along with an age-squared term given observednon-
linearity. Backwards elimination was employed, retaining covariates significant at P< 0.10;
this included age, age-squared, severity of illness (APACHE III), hospital, socioeconomic sta-
tus, acute renal failure, medical diagnosis and trauma. After adjustment, stress induced hyper-
glycemia remained an independent risk factor for incident diabetes, with an adjusted sub-
hazard ratio of 1.91 (1.62, 2.26), P< 0.001. A post hoc sensitivity analysis limiting the duration
of observation to four years did not alter this signal (adjusted sub-hazard ratio: 2.16 (1.8,
2.58)). There was a positive non-linear relationship betweenNDSS registration and maximum
blood glucose level, with a marked increase in risk at blood glucose levels>7.8 mmol/L (S2
Fig). A sensitivity analysis performed against SIH, with a cut-off blood glucose value of 7.8
mmol/L [18, 19], was associated with a sub-hazard ratio of 2.07 (1.78, 2.43), P<0.0001).
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Fig 1. CONSORT style flowchart of patients included in analysis. SIH, stress induced hyperglycemia.
doi:10.1371/journal.pone.0165923.g001
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Effect of age on risk of incident diabetes
The association of age with the risk of incident diabetes was non-linear, with both age and age-
squared terms being significant in the multivariate model, P<0.0001 respectively. In order to
visualise this relationship, age was grouped into approximate deciles and the risk of diabetes
estimated for each group; peak risk occurring in the 50–59 age-group, sub-hazard ratio 7.90
(5.38, 11.60), with risk decreasing steadily thereafter (Fig 3).
Mortality
The 8 year mortality rate for survivors of critical illness without known diabetes was 34%
(5,843 of 17,074). Unadjusted proportional hazards regression suggested an increased risk of
death associated with stress induced hyperglycaemia (Fig 4); however, this signal was no longer
present after adjusting for age and severity of illness (hazard ratio 1.04 (0.97, 1.11), P = 0.276).
Discussion
The key finding of this study is that stress induced hyperglycemia appears to approximately
double the risk of incident diabetes in survivors of critical illness. This is the largest study to
assess the long term risk of incident diabetes in survivors of critical illness and includes all
patients admitted to a public hospital ICU over a prolonged observational period.
The key finding is biologically plausible and consistent with epidemiological studies report-
ing an association between hyperglycemia during hospitalization and subsequent diabetes [16,
18, 20, 21]. The most externally valid of these, a retrospective cohort study of over 86,000
admissions to emergency departments in Scotland, reported that patients who are hyperglyce-
mic (blood glucose> 11 mmol/L (200 mg/dL)) had a three-year risk of developing diabetes of
10%, compared to 2.3% in all patients admitted to the emergency department [16]. However,
Table 1. Demographic data by study group.
Normoglycemia Stress Induced Hyperglycemia Total
Separations, n (% total) 14,191 (63) 2,883 (13) 17,074
Male, n (% group) 8,522 (60) 1,635 (57) 10,157 (59)
Site, n (% group)
A 5,009 (35) 961 (33) 5,970 (35)
B 5,180 (37) 996 (35) 6,176 (36)
C 2,245 (16) 576 (20) 2,821 (17)
D 1,757 (12) 350 (12) 2,107 (12)
ATSI, n (% group) 443 (3.1) 72 (2.5) 515 (3.0)
Age, mean (SD) 56.7 (20.0) 61.8 (17.6) 57.4 (19.7)
APACHE III, med (IQR) 52 (36, 69) 67 (50, 87) 54 (38, 72)
Length of Stay, med (IQR)
ICU 1.9 (1.0, 3.9) 2.7 (1.4, 5.6) 2.0 (1.0, 4.1)
Hospital 11.1 (5.9, 21.1) 13.0 (7.2, 24.6) 11.4 (6.1, 21.7)
Acute Renal Failure, n (% grp) 308 (2.2) 111 (3.9) 419 (2.5)
Peak BG, med (IQR) 7.8 (6.6, 9.0) 12.7 (11.7, 14.4) 8.3 (6.9, 10)
Medical, n (% group) 8,463 (59.6) 1,910 (66.3) 10,373 (60.8)
Surgical, n (% group) 5,728 (40.4) 973 (33.8) 6,701 (39.3)
Trauma, n(% group) 1,552 (10.94) 165 (5.72) 1,717 (10.6)
ATSI Aboriginal and Torres Strait Islander peoples, APACHE Acute Physiology and Chronic Health Evaluation, BG Blood Glucose (mmol/L).
doi:10.1371/journal.pone.0165923.t001
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only 1,853 (2%) patients were admitted to an ICU with only 37 (0.04%) of these developing
diabetes [16].
There are limited data relating to the relationship between stress induced hyperglycemia
and the development of type 2 diabetes in survivors of critical illness [19, 22, 23]. In a prospec-
tive observational study from a single ICU, Gornik and colleagues performed annual oral glu-
cose tolerance tests for 5 years in 582 survivors of critical illness, stratifying patients into
normoglycemia and stress induced hyperglycemia based on peak inpatient blood glucose [19].
Patients with stress induced hyperglycemia (peak blood glucose> 7.8 mmol/l (140.4 mg/dL)
had a five-fold increased risk of incident type 2 diabetes [19]. The external validity of these
results is diminished by the lack of severity of illness data and the relatively high proportion of
patients receiving total parenteral nutrition (32%) [19]. In a similar, single-centre study Van
Ackerbock and colleagues performed an oral glucose tolerance test 8 months post ICU dis-
charge in 338 survivors of critical illness [22]. Hyperglycemia (peak blood glucose> 7.8 mmol/
L (140.4 mg/dL)) did not identify patients at risk of incident diabetes, possibly reflecting the
short time period for diagnosis of incident diabetes and the relatively small sample size.
For this study, given that fasting status was unknown, stress induced hyperglycemia was
defined using the American Diabetes Association Diabetes in Hospitals Writing Committee
Fig 2. Cumulative incidence for type 2 diabetes for the control group (blue line) versus stress induced hyperglycemia (red line).
doi:10.1371/journal.pone.0165923.g002
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Guidelines, i.e. random blood glucose 11.1 mmol/L (200 mg/dL) [24]. This threshold has also
been proposed as the cut-off at which screening programsmay be beneficial [16]. The risk of inci-
dent diabetes varied according to age, with the greatest risk demonstrated in patients aged 50–59,
and in this sub-group stress induced hyperglycemia was associatedwith a seven-fold increased
risk of incident diabetes. This is likely to be important because for any diabetes screening pro-
gram to be cost-effective they must identify younger populations who have the greatest capacity
to benefit early intervention [25]. Accordingly, these data provide a persuasive rationale for the
evaluation of screening programs in a relatively young population of ICU survivors.
This study has several important limitations. New registration with the NDSS was used as a
surrogate marker for incident diabetes.While the true incidence of diabetes is likely higher
than reported in this study, there is no reason to expect bias in NDSS registration between
groups, and so NDSS registration is likely to be a valid surrogate.
Peak blood glucose in the first 24 hours was utilised as the sole metric for classifying stress
induced hyperglycemia, missing those patients in whom hyperglycemia was delayed. While
this may have resulted in some patient misclassification, it is reassuring that blood glucose con-
centrations within the first 24 hours are predictive of glycaemic control throughout ICU
admission [26]. A further limitation was our inability to quantify whether risk was increased
following sustained duration of stress induced hyperglycemia.
Feeding status was not available and patients with fasting blood glucose 7.0–11.0 mmol/L
(126–198 mg/dL) [24] may have beenmissed. This is supported by the sharp rise in risk at a
blood glucose 7.8 mmol/L (141 mg/dL), likely reflecting the population of fasting patients
Fig 3. Sub-hazard ratios for the risk of type 2 diabetes by glycemic category and age group. Control
group = blue bars; stress induced hyperglycemia = red bars. Age is grouped approximately into deciles with
normoglycemia and age 18–29 years as the base reference; Data are sub-hazard ratios ± 95% confidence
intervals.
doi:10.1371/journal.pone.0165923.g003
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with unrecognisedSIH and underestimation of the true hazard rate. Furthermore, insulin infu-
sion protocols differed between units, which may have modifiedpeak glycaemia. However,
while there was a statistically significant difference in mean peak blood glucose between units,
this was only 0.6 mmol/L (10.8 mg/dL) and unlikely to be of substantive clinical relevance or to
have biased hazard estimates and was included in the multivariate model. Missing blood glu-
cose or demographic data resulted in approximately 10% of patient separations being excluded
from potential matching; however, this exclusion rate is comparable to previous cohort studies
using blood glucose data from the ANZICS-APD and most frequently occurs with brief admis-
sions where no blood tests are recorded [27]. There were no data available on bodymass index
(BMI) or other known risk factors for the development of diabetes such as alcohol consump-
tion or family history of impaired glucose tolerance. It is somewhat reassuring however, that a
prospective observational study in a similar cohort reported that once patients with undiag-
nosed diabetes are excluded increasing BMI does not identify a group of patients and increased
risk of stress induced hyperglycemia [2]. Notwithstanding limitations inherent to epidemiolog-
ical studies, it should be recognized that unmeasured factors may have confounded risk esti-
mates. Future prospective studies that assess incident diabetes in survivors of critical illness
and account for all potential confounders are therefore needed.
Fig 4. Kaplan-Meier survival curves for the control group (blue line) and stress induced hyperglycemia (red line) from hospital
discharge to 8 years.
doi:10.1371/journal.pone.0165923.g004
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As glycated hemoglobin (HbA1c) is not routinely measured on ICU admission, the propor-
tion of patients classified as having stress induced hyperglycemia who actually had prevalent
but unrecognised type 2 diabetes is unknown. Previous epidemiological studies report the prev-
alence of unknown diabetes to be between 5 and 10% of patients admitted to ICU [2, 28]. To
limit the likelihoodof unknown diabetes being a major confounder prevalent diabetes was
identified by a thorough process including verifying across two separate databases (using ICD-
10 codes and NDSS registration) and excluding patients with a blood glucose> 20 mmol/L
(360 mg/dL), or who registered with the NDSS within 30 days of hospital discharge, were
excluded [16]. Moreover, in a recent study from one of the four participating ICUs 5.5% of
admitted patients had previously unrecogniseddiabetes (i.e. HbA1c 6.5% (47.5 mmol/mol))
[2], which suggests that the rate of undiagnoseddiabetes appears to be relatively infrequent in
South Australia. Nonetheless, the potential that undiagnoseddiabetes may have biased hazard
estimates cannot be excluded.
Clinical implications
In the U.S. alone annual admissions to intensive care units total more than 5.7 million [29].
Epidemiological data indicate that stress induced hyperglycaemia occurs frequently [2].
Accordingly, there are a large number of patients who survive ICU with stress hyperglycaemia
whomay benefit from earlier detection of incident diabetes. There are major benefits in identi-
fying individuals at risk of incident diabetes, including prompt diagnosis facilitating earlier
treatment thereby reducing complication rates [30, 31], with current guidelines in many
regions recommend screening high-risk individuals [32]. Studies are now warranted to deter-
mine the efficacyof such screening programs for patients with stress induced hyperglycemia
who survivor critical illness.
Conclusions
Acute hyperglycemia during critical illness identifies patients at substantially greater risk of
incident diabetes following hospital discharge. The risk of incident diabetes appears to be great-
est in middle-aged patients, which may have implications for screening of this population.
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